NCT02749578View on ClinicalTrials.gov

Drug Interaction Study of MGL-3196 With Atorvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Healthy
Interventions
DRUG

Atorvastatin

DRUG

MGL-3196

Trial Locations (1)

85283

Celerion, Tempe

Sponsors

Collaborators (1)

Celerion
All Listed Sponsors
collaborator

Celerion

INDUSTRY

lead

Madrigal Pharmaceuticals, Inc.

INDUSTRY

NCT02749578 - Drug Interaction Study of MGL-3196 With Atorvastatin | Biotech Hunter | Biotech Hunter